{"database": "lobbying", "table": "lobbying_activities", "rows": [[748039, "34c4d2eb-cb19-4032-885c-9c6eb989d5c6", "Q1", "TIMMONS AND COMPANY, INC.", 38164, "TEVA PHARMACEUTICALS USA INC", 2009, "first_quarter", "LBR", "H.R. 1706 - To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and for other purposes. \nS. 369 - A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market.", "HOUSE OF REPRESENTATIVES,SENATE", 100000, null, 0, 0, "2009-04-13T15:09:30-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["748039"], "units": {}, "query_ms": 0.5045919970143586, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}